Ruah Alyamany: Evaluating Safety of TPO-RA Use in ITP After Splenectomy
Ruah Alyamany, Advanced Classical (Benign) Hematology Fellow at Mayo Clinic, shared a post on LinkedIn:
“Excited to share our latest study in ITP.
In clinical practice, esp. in classical (benign) hematology, safety and risk can be easily assumed rather than examined. In ITP, many patients receive TPO-RAs after splenectomy without full consideration of potential consequences. Here we take a closer look, evaluating their general safety in this setting and with a closer look at thrombosis.”
Read the full article here.
Title: Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP
Authors: Ruah Alyamany, Damon E Houghton, Meera Sridharan, Rajiv K Pruthi, Surbhi Shah, Richard C. Godby, Alexandra P Wolanskyj-Spinner, Ronald S. Go
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Jun 8, 2026, 06:30Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
-
Jun 8, 2026, 06:25Cécile Jefford: The NEHA Community and the Power of Human Connection
-
Jun 8, 2026, 06:02Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together